Photo

US$ 1.5 billion for pneumococcal vaccines development

Canada, Italy, Norway, Russia, the United Kingdom, and the Bill & Melinda Gates Foundation today committed US$1.5 billion to launch a pilot Advance Market Commitment (AMC) to help speed the development and availability of a new vaccine which is expected to save the lives of 5.4 million children by 2030. The new initiative will target pneumococcal disease, a major cause of pneumonia and meningitis…

Neurobiology

The 2006 Eppendorf and Science prize, the annual international research prize of US$25,000 has been awarded to Doris Tsao PhD, of the USA.

Drug trials

Small and medium-size contract research organisations (CROs) have huge potential. For the last few decades, pharmaceutical companies have increasingly chosen to use medium-size contract research organisations (CROs), or smaller organisations, rather than the larger organisations, due to their enhanced responsiveness and flexibility, that provides good geographic coverage, a broad therapeutic…

51 show more articles
Subscribe to Newsletter